 | UroGen Pharma Ltd. | |||
| NasdaqGM : URGN || Location: United States | ||||
$8.345+0.15 (+1.77%) |
0.0 M | 8.31 - 8.345 | ||
| Last Updated:08/10/2022 09:45 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 15, 2022 | 1.523 M |
| June 30, 2022 | 1.703 M |
| June 15, 2022 | 2.179 M |
| May 31, 2022 | 2.443 M |
| May 13, 2022 | 2.358 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2022 | -1.33 | -1.25 | 6.00% |
| 12/31/2021 | -1.17 | -1.27 | -8.50% |
| 09/30/2021 | -1.29 | -1.35 | -4.70% |
| 06/30/2021 | -1.13 | -1.17 | -3.50% |
| 03/31/2021 | -1.29 | -1.17 | 9.30% |
URGN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 22.693M | Shares Float | 19.088M |
| Short Float | 1.523M | Market Cap | 195.84M |
| Institution ownership | 79.74% | Insider ownership | 8.959% |
| Earnings Date | 08/11/2022 BMO | Cash Per Share | ? |
| Trailing EPS | -5.05 | Forward EPS | -3.59 |